Randomized Phase 2, Dose-finding Efficacy, Safety Study of ANF-RHO™ Versus Neulasta® in Chemotherapy-Induced Neutropenia
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Chemotherapy-induced Neutropenia
Interventions: DRUG: ANF-RHO™|DRUG: Neulasta®
Sponsor: Prolong Pharmaceuticals